Cargando…
TNBC: Potential Targeting of Multiple Receptors for a Therapeutic Breakthrough, Nanomedicine, and Immunotherapy
Triple-negative breast cancer (TNBC) is a heterogeneous, recurring cancer associated with a high rate of metastasis, poor prognosis, and lack of therapeutic targets. Although target-based therapeutic options are approved for other cancers, only limited therapeutic options are available for TNBC. Cel...
Autores principales: | Singh, Desh Deepak, Yadav, Dharmendra Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389539/ https://www.ncbi.nlm.nih.gov/pubmed/34440080 http://dx.doi.org/10.3390/biomedicines9080876 |
Ejemplares similares
-
Role of PARP in TNBC: Mechanism of Inhibition, Clinical Applications, and Resistance
por: Singh, Desh Deepak, et al.
Publicado: (2021) -
Current Potential Therapeutic Approaches against SARS-CoV-2: A Review
por: Yadav, Dharmendra Kumar, et al.
Publicado: (2021) -
A Clinical Update on SARS-CoV-2: Pathology and Development of Potential Inhibitors
por: Singh, Desh Deepak, et al.
Publicado: (2023) -
CRISPR/Cas9 based genome editing for targeted transcriptional control in triple-negative breast cancer
por: Deepak Singh, Desh, et al.
Publicado: (2021) -
Recent Clinical Advances on Long Non-Coding RNAs in Triple-Negative Breast Cancer
por: Singh, Desh Deepak, et al.
Publicado: (2023)